Home › News & events › In the Media

In the Media

 

A new path to stimulate the immune system and fight against infections - Science Magazine January 20, 2012

A research lead by Eric Vivier and Sophie Ugolini of the Centre d'Immunologie de Marseille-Luminy (CIML - Inserm/CNRS/Aix Marseille Université) has revealed a new gene that, when mutated, stimulates the immune systems to fight better against tumours and viral infections.

See the abstract on Science magazine website

More on the CIML website

Media coverage :

The Telegraph: Drug that turbo charges the immune system could fight off colds and flu

 

France Inter

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialise correctly.

 

 

LCI, le journal

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialise correctly.

 

Hervé Brailly was invited on Radio Classique on december 9, 2011

 

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialise correctly.

 

Therapeutic Workshop "Immunotherapy: Heal Thyself" at the 10th annual Bio Investor Forum -  October 25, 2011, San Francisco, CA

 

Moderator: Jason Kantor, PhD, Managing Director, RBC Capital Markets

Panelists:

Hervé Brailly, PhD, Chief Executive Officer, Innate Pharma SA, 

Kevin N. Heller, MD, Director, Immuno-Oncology- Strategic Transactions Group, Bristol-Myers Squibb Company

Carlos Paya, MD, PhD, President & Chief Executive Officer, Immune Design Corp.

Timothy C. Rodell, MD, Chief Executive Officer & President, Globeimmune, Inc

 

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialise correctly.

 

 Hervé Brailly, CEO and general manager of the Company, was at the Agora of Presidents on Actionaria (November 18, 2011, Paris, France)

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialise correctly.

 

Nobel Prize for Innate Immunity

Nobel Prize for Medicine awarded to Ralph Steinman (Rockefeller, US), Bruce Beutler (Scripps, US) and Jules Hoffmann (Strasbourg, France).

Recognition of Beutler and Hoffman’s “discoveries concerning the activation of innate immunity” and Steinman’s work for his discovery of the dendritic cell and its role in adaptive immunity.

Their work has opened up new avenues for the development of new therapies against infections, cancer, and inflammatory diseases.

► See press release at nobelprize.org

 

 

Agreement between Bristol-Myers Squibb and Innate Pharma signed on July 6, 2011 - Selection of French TV and radio coverage

 

LCI, 11/07/06

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialise correctly.

 

BFM tv, 11/07/06

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialise correctly.

 

France 3 Marseille, 11/07/06

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialise correctly.

 

Radio RFI, 11/07/07

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialise correctly.

 

 

Roundtable "Immunotherapy: Pushing the boundaries in oncology"(in French only).

► Discover the video of the roundtable which took place in 2010 in Marseilles

 

This roundtable was organised at the CIML, in Marseilles, France, to celebrate the 10th anniversary of Innate Pharma and Ipsogen.

At this occasion, opinion leaders in economics, research and oncology, as well as directors from biotech and pharmaceutical companies, got together to share and compared their views on three topics: cancer immunotherapy, molecular diagnosis of cancer and the French biotech pipeline.